Novel self-assembled nanoparticles of testosterone- modified glycol chitosan and fructose chitosan for controlled release

Journal of Biomaterials and Tissue Engineering

Volumn 3, Issue 1, 2013, Pages 164-172

  Quiñones, Javier Pérez ^a,b   Gothelf, Kurt V ^c,d   Kjems, Jørgen ^c,d   Heras, Angeles ^d,e   Schmidt, Claudia ^d,f   Peniche, Carlos ^a,d  

^a UNIVERSITY OF HAVANA   (Cuba)

^b Interdisciplinary Nanoscience Center iNANO Aarhus University ^*  (Cuba)

^c AARHUS UNIVERSITY   (Denmark)

^d Department of Chemistry University of Paderborn ^*  (Cuba)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^f UNIVERSITY OF PADERBORN   (Germany)

Author keywords

Chitosan; Controlled release; Self aggregated nanoparticles; Testosterone

Indexed keywords

CHITOSAN DERIVATIVE; FRUCTOSE CHITOSAN; GLYCOL CHITOSAN; NANOPARTICLE; TESTOSTERONE; TESTOSTERONE HYDROGEN SUCCINATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY DIFFRACTION;

EID: 84891607643     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2013.1071     Document Type: Article

References (39)

1. N. Arguedas, M. E. Clark, E. D. Ketterson, D. S. Monk, V. Nolan, P. G. Parker, S. A. Raouf, W. L. Reed, and E. Snajdr, Physiological effects on demography: A long-term experimental study of testosterone's effects on fitness. American Nature 167, 667 (2006).
2. R. M. Cox and H. B. John-Alder, Testosterone has opposite effects on male growth in lizards (Sceloporus spp.) with opposite patterns of sexual size dimorphism. J. Experim. Biology 208, 4679 (2005).
3. S. Alkaade, N. Bassil, and J. E. Morley, The benefits and risks of testosterone replacement therapy: A review. Therapy Clinical Risk Management 5, 427 (2009).
4. S. Bandelow, M. Combrinck, E. Hogervorst, and A. D. Smith, Low free testosterone is an independent risk factor for Alzheimer's disease. Experimental Gerontology 39, 1633 (2004).
5. C. Bouchard, G. D. Braunstein, S. R. Davis, M. Gass, A. L. Hirschberg, H. Koch, R. Kroll, M. Moreau, A. Moufarege, S. Pack, N. Panay, C. Rodenberg, and J. Studd, Testosterone for low libido in postmenopausal women not taking estrogen. New England Journal Medicine 359, 2005 (2008).
6. R. M. Francis and S. P. Tuck, Testosterone, bone and osteoporosis. Frontier Hormone Research 37, 123 (2009).
7. A. Aleman, J. L. Bosch, M. H. Emmelot-Vonk, D. E. Grobbee, T. M. Lock, H. R. Nakhai-Pour, Y. T. van der Schouw, and H. J. Verhaar, Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: A randomized controlled trial. Journal of the American Medical Association 299, 39 (2008).
8. M. L. Andersen and S. Tufik, The effects of testosterone on sleep and sleep-disordered breathing in men: Its bidirectional interaction with erectile function. Sleep Medical Reviews 12, 365 (2008).
9. A. Morgentaler and C. Schulman, Testosterone and prostate safety. Frontier Hormones Research 37, 197 (2009).
10. W. H. Walker, Molecular mechanisms of testosterone action in spermatogenesis. Steroids 74, 602 (2009).
11. N. Beheshti, A.-L. Kjøniksen, K. D. Knudsen, B. Nyström, and K. Zhu, Rheological and structural aspects on association of hydrophobically modified polysaccharides. Soft Matter. 5, 1328 (2009).
12. M. Chen, R. Li, X. Li, L. Liu, Y. Liu, Y. Wang, W. Yang, Q. Zhang, and Z. Zhou, Preparation and characterization of self-assembled nanoparticles of 6-O-cholesterol-modified chitosan for drug delivery. Carbohydrate Polymers 84, 1244 (2011).
13. Y. Jing-Mou, Q. Li-Yan, J. Yi, and L. Yong-Jie, Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: Preparation and in-vitro and in-vivo characterization. Journal of Pharmacy and Pharmacology 61, 713 (2009).
14. K. Fink, S. Höhne, F. Simon, and S. Spange, Hydrophobically functionalized chitosan particles. Journal of Adhesion Science and Technology 23, 297 (2009).
15. R. A. A. Muzzarelli, Chitin, Pergamon Press, Oxford (1997).
16. S. Bagheri-Khoulenjani, H. Mirzadeh, and S. M. Taghizadeh, An investigation on the short-term biodegradability of chitosan with various molecular weights and degrees of deacetylation. Carbohydrate Polymers 78, 773 (2009).
17. S. Dhaliwal, S. Jain, H. P. Singh, and A. K. Tiwary, Mucoadhesive microspheres for gastroretentive delivery of acyclovir: In vitro and in vivo evaluation. The American Association of Pharmaceutical Scientists Journal 10, 322 (2008).
18. D. Raafat and H.-G. Sahl, Chitosan and its antimicrobial potential-A critical literature survey. Microbial Biotechnology 2, 186 (2009).
19. V. G. Babak, T. A. Babushkina, T. P. Klimova, E. A. Stepnova, V. E. Tikhonov, and E. V. Vorontsov, New approach to the quaternization of chitosan and its amphiphilic derivatives. European Polymer Journal 43, 2414 (2007).
20. Y. Jing-Mou, Q. Li-Yan, J. Yi, and L. Yong-Jie, Self-aggregated nanoparticles of cholesterol-modified glycol chitosan conjugate: Preparation, characterization, and preliminary assessment as a new drug delivery carrier. European Polymer Journal 44, 555 (2008).
21. Y. W. Cho, H. Chung, S. Y. Jeong, K. Kim, J. H. Park, and Y. J. Son, Preparation and characterization of self-assembled nanoparticles based on glycol chitosan bearing adriamycin. Colloid Polymer Science 284, 763 (2006).
22. Y. C. Chung, C. F. Li, and C. F. Tsai, Preparation and characterization of water-soluble chitosan produced by Maillard reaction. Fisheries Science 72, 1096 (2006).
23. X. Chen, K. Choi, Y. Choi, S. Y. Jeong, J. F. Leary, D.-E. Lee, S. Lee, S. J. Lee, K. Kim, H. Koo, I. C. Kwon, S. Min, and K. Park, Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials 32, 4021 (2011).
24. H. Chung, S. Y. Jeong, K. Kim, I. C. Kwon, S. Kwon, and J. H. Park, Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. Biomacromolecules 6, 1154 (2005).
25. B. C. Amsden, D. K. Knight, and S. N. Shapka, Structure, depolymerization, and cytocompatibility evaluation of glycol chitosan. Journal of Biomedical Materials Research Part A 83A, 787 (2007).
26. X. G. Chen, M. Kong, C. G. Liu, C. S. Liu, X. H. Meng, and L. J. Yu, Antibacterial mechanism of chitosan microspheres in a solid dispersing system against E. coli. Colloids Surf. B: Biointerfaces 65, 197 (2008).
27. Y. Du, H. Li, Y. Liu, C. Qin, Q. Xiao, and J. Zhu, Water-solubility of chitosan and its antimicrobial activity. Carbohydrate Polymers 63, 367 (2006).
28. T. Kean and M. Thanou, Biodegradation, biodistribution and toxicity of chitosan. Advanced Drug Delivery Reviews 62, 3 (2010).
29. T. Abe, K. Hasunuma, and M. Kurokawa, Vitamin E orotate and a method of producing the same, US Patent 3944550 (1976).
30. A. Martínez-García and R. Martínez, Microwave assisted synthesis of diosgenin esters of maleic and itaconic acids. Synthetic Communications 38, 1917 (2008).
31. C.-C. Chen, Y.-C. Chung, and C.-L. Kuo, Preparation and important functional properties of water-soluble chitosan produced through Maillard reaction. Bioresource Technology 96, 1473 (2005).
32. C. P. Covas, J. P. Quiñones, C. Schmidt, and R. Szopko, Novel drug delivery systems: Chitosan conjugates covalently attached to steroids with potential anticancer and agrochemical activity. Carbohydrate Polymers 84, 858 (2011).
33. E. R. Dockal, J. E. Santos, and J. P. Soares, Characterizacao de quitosanas comerciais de diferentes origens. Polimeros: Ciencia e Tecnologia 13, 242 (2003).
34. Y. Coll, H. Curiel, C. Peniche, and J. Pérez, Microspheres of chitosan for controlled delivery of brassinosteroids with biological activity as agrochemicals. Carbohydrate Polymers 80, 915 (2010).
35. A. I. Gray, L. Noble, L. Sadiq, and I. F. Uchegbu, A non-covalently cross-linked chitosan based hydrogel. International Journal of Pharmaceutics 192, 173 (1999).
36. A. I. Gray, A. Mahmoud, L. Sadiq, A. G. Schätzleinä, I. F. Uchegbu, R. D. Waigh, and W. Wang, Quaternary ammonium palmitoyl glycol chitosan-A new polysoap for drug delivery. International Journal of Pharmaceutics 224, 185 (2001).
37. M. Berrada, M. D. Buschmann, A. Gupta, M. Lavertu, A. Rodrigues, A. N. Serreqi, D. Wang, and Z. Xia, A validated 1H NMR method for the determination of the degree of deacetylation of chitosan. Journal of Pharmaceutical and Biomedical Analysis 32, 1149 (2003).
38. 1H NMR spectroscopy. Polym. Bull. 26, 87 (1991).
39. L. David, A. Domard, J.-M. Lucas, A. Osorio-Madrazo, C. Peniche-Covas, and S. Trombotto, Kinetics study of the solid-state acid hydrolysis of chitosan: Evolution of the crystallinity and macromolecular structure. Biomacromolecules 11, 1376 (2010).